34 Systemic hypoxia is a physiological and pathophysiological stress that activates the 35 sympathoadrenal system and, in young adults, leads to peripheral vasodilation. We tested the 36 hypothesis that peripheral vasodilation to graded systemic hypoxia is impaired in older healthy 37 adults and that this age-associated impairment is due to attenuated β-adrenergic mediated 
Introduction

81
In humans and experimental animals, acute systemic hypoxia evokes autonomic reflex 82 responses and alterations in the synthesis of a variety of vasoactive substances within the 83 circulation, blood vessels, and local tissue, all of which contribute to the control of vascular tone 84 (35, 36) . In many vascular beds including cerebral (3), coronary (37), and skeletal muscle (21, 85 52), the net effect of these changes in response to systemic hypoxia is vasodilation. In the interaction between the sympathoadrenal system and locally-derived substances that ultimately 99 determine the net peripheral vasodilatory response to systemic hypoxia in humans.
100
Many changes in both autonomic circulatory control and peripheral vascular function 101 occur with advancing age, predisposing older adult humans to both acute (e.g. myocardial 102 5 infarction, stroke) and chronic (e.g. hypertension, atherosclerosis, ischemic vascular disease) 103 cardiovascular complications (51). Systemic hypoxia is not only a physiological stressor, but 104 may be a significant pathophysiological stressor observed in disease states such as obstructive 105 sleep apnea and congestive heart failure, both of which increase in prevalence with advancing 106 age (4, 7). One of the most pronounced and repeatable findings with human aging is the 107 progressive increase in basal (resting) MSNA that is typically 2-3 fold higher in older compared 108 with young healthy adults (15, 19, 20, 39) . We have previously demonstrated that this elevated 109 sympathetic activity with age does not translate to greater basal forearm vasoconstriction due to 110 reduced α-receptor responsiveness at rest (18, 42) . Regarding sympathetic responses to systemic 111 hypoxia, the acute increase in MSNA is not different with age (14, 26) , however, our 112 understanding of how post-junctional α-receptor signaling interacts with circulating epinephrine 113 or other local vasodilatory factors to regulate vascular tone in older adults during a hypoxic 114 stimulus is currently unknown. In this context, circulating epinephrine appears to increase to a 115 similar extent in young and older adults (11), yet given potential changes in β-receptor 116 responsiveness with age (16, 40, 49) , the net effect of sympathoadrenal activation on the 117 regulation of vascular tone during hypoxia is also unknown.
118
Human aging is also characterized by vascular endothelial dysfunction, which results in 119 reduced NO bioavailability (47, 48) , a potential shift from predominantly vasodilator (e.g. 120 prostacyclin) to vasoconstrictor (e.g. thromboxane) prostanoid production (48), and increased 121 endothelin-1 (ET-1) mediated vasoconstriction(53). Additionally, we have recently reported 122 impaired ATP release from erythrocytes of older healthy adults in response to hypoxia, and this 123 was related to a lack of increase in plasma ATP and impaired forearm vasodilation during a 124 single level of systemic hypoxia (80% SpO 2 ) (27). In theory, any change in autonomic 125 6 circulatory control or in the bioavailability of these local substances could alter the net vascular 126 response to systemic hypoxia in older adults and contribute to the observed impairment in 127 hypoxic vasodilation with age. 
Methods
138
Subjects
139
With Institutional Review Board approval and following written informed consent, a total 140 of 12 young (4 female, 8 male) and 10 older (4 female, 6 male) healthy subjects participated in 141 the present study. All subjects were free from overt cardiovascular disease as assessed from a 142 medical history, were sedentary to moderately active, non-smokers, non-obese, normotensive,
143
and not taking any medications including over the counter supplements (Table 1) 
Arterial Catheterization
154
The non-dominant arm was chosen to be the experimental arm and after local application 155 of anesthesia (2% lidocaine), a 20-guage, 7.6 cm catheter was inserted into the brachial artery 156 utilizing aseptic technique. The catheter was connected to a pressure transducer for continuous 157 monitoring of mean arterial pressure (MAP) as well as a 3-port connector to allow for drug 158 infusions and blood sampling (18, 34) . Throughout the duration of the study, heparinized saline 159 (2 U/mL) was continuously infused at a rate of 3 ml/minute. Heart rate (HR) was monitored via 
Graded Systemic Isocapnic Hypoxia
172
To elicit graded systemic hypoxia, we utilized a self-regulating partial re-breathe system 173 (2, 21, 34) which allows for constant alveolar fresh air ventilation independent of changes in 174 minute ventilation and enables end-tidal CO 2 (EtCO 2 ) to be clamped (2). Oxygen (O 2 ) levels 175 were titrated down by mixing nitrogen with air in a medical gas blender to attain steady arterial 176 O 2 saturations (SaO 2 ) of 90, 85, and 80% as assessed by pulse oximetry (SpO 2 ) of the earlobe.
177
Nasal breathing was prevented through the use of a nose clip while subjects breathed through a 178 scuba mouthpiece. An anesthesia monitor was used to monitor gas concentrations at the level of 
Forearm Blood Flow (FBF) and Vascular Conductance (FVC)
184
Brachial artery mean blood velocity (MBV) and diameter was determined using a 12
185
MHz linear-array ultrasound probe (Vivid 7, General Electric, Milwaukee, WI, USA). The 186 probe was securely fixed to the skin over the brachial artery proximal to the catheter insertion 187 site as previously described (13). During blood velocity measurements, the probe insonation ml/min, the MBV is in cm/s, the brachial diameter is in centimeters, and 60 was used to convert 195 from ml/s to ml/min. Forearm vascular conductance (FVC) was calculated as (FBF/MAP) ×100,
196
and expressed as ml/min/100mmHg (6, 31). continued the infusion at a maintenance rate (5 µg/dL/FAV/min) throughout the hypoxia trial.
215
Loading doses of the drugs were given at 2 ml/min via Harvard infusion syringe pump, and 216 maintenance doses were given at 1 ml/min. These doses were chosen based on previous studies 217 in our laboratory demonstrating effective adrenergic blockade (18, 22, 34) . 
Experimental Protocol
228
The overall study timeline is presented in Figure 1 . All participants arrived in the 229 morning after an overnight fast. All measurements were performed with the subjects in the 230 supine position within a cool temperature controlled room (21 o C). A fan was directed toward 231 the forearm to limit skin blood flow, and a wrist cuff was inflated to exclude the hand circulation 232 from our forearm hemodynamic measures (12).
233
Following placement of the brachial catheter, subjects rested quietly for a minimum 30 234 minutes. To begin, α-and β-adrenergic receptor responsiveness was randomly assessed using 235 norepinephrine and isoproterenol, respectively. To do so, following 2 minutes of baseline 
Results
289
Subject Characteristics
290
The mean age difference between young and older subjects was 39 years. There were no 291 significant age-group differences in any measure of whole-body anthropometrics or regional 292 tissue composition. Triglycerides and HDL-cholesterol were also not different between groups.
293
Although within a normal range, older adults had significantly greater total and LDL-cholesterol 294 (Table 1 ).
296
FBF and FVC Responses to Graded Systemic Hypoxia
297
There were no significant differences in resting FBF or FVC between young and older 298 adults (Table 2) . During the control hypoxia trial, young individuals exhibited progressive 299 vasodilation in response to graded hypoxia (peak ΔFVC at 80% SpO 2 = 35±8%; P<0.05 vs. 300 zero), whereas older adults failed to vasodilate significantly at any level of SpO 2 (peak ΔFVC = 301 4±6%; P<0.05 vs. young; Figure 2A ) and the response was blunted compared to young adults at 302 all levels of hypoxia (P<0.05). β-adrenergic receptor blockade did not impact FBF or FVC at rest in either group (Table   304 2). Following local β-adrenergic receptor blockade, young adults continued to exhibit net 305 vasodilation during hypoxia, the magnitude of which was only slightly less than that observed in 306 control conditions (peak ΔFVC at 80% SpO 2 = 28±8 vs. 35±8%; P = 0.29; Figure 2B ).
307
Conversely, older adults actively constricted in response to graded systemic hypoxia during β-308 14 adrenergic blockade which was significant at 85 and 80% SpO 2 (peak ΔFVC at 80% SpO 2 = -309 13±6%; P<0.05 vs. zero; Figure 2B ), and again, demonstrated impaired responses compared to 310 young adults at all levels of hypoxia (P<0.05).
311
As expected, α-adrenergic receptor blockade significantly increased FBF and FVC at rest 312 in both young and older adults (Table 2) . During the third hypoxia trial, when both α-adrenergic 313 vasoconstriction and β-adrenergic mediated vasodilation were inhibited, young adults still 314 exhibited significant forearm vasodilation, the magnitude of which was augmented compared 315 with control and β-blockade conditions at 85 and 80% SpO 2 (peak ΔFVC at 80% SpO 2 = 316 57±11%; P <0.05 vs. control). In contrast, the older adults failed to significantly vasodilate from 317 rest at any level of hypoxia (peak ΔFVC = 12±11%; P = 0.32 vs. zero) and the age-associated 318 impairment in peripheral vasodilation persisted across all levels of hypoxia ( Figure 2C ). 
Effects of Graded Systemic Hypoxia on Ventilation, Blood Gases, and Arterial Catecholamine
321
Concentrations
322
At rest, there were no significant differences between young and older adults with respect 323 to ventilation (Table 3) and resting blood gases (Table 4) . Further, there was no effect of time 324 (hypoxic bout) or age on ventilatory or blood gas responses to hypoxia. There were no 325 significant differences in resting arterial catecholamine concentrations between young and older 326 adults in any condition (control, β-blockade, and α+β-blockade; Table 4 ). Arterial epinephrine 327 concentrations increased with the level of hypoxia in both young and older adults in the control 328 trial, and the increase was less in older adults at 80% SpO 2 (P<0.05). Similar patterns of 329 response were observed in the subsequent hypoxia trials, with epinephrine concentrations being 330 elevated at rest and during hypoxia in the third trial in both groups (α+β-blockade trial; P<0.05).
331
Arterial norepinephrine was not different in young and older adults at rest in the control trial, and 332 did not significantly increase during graded systemic hypoxia in either group. Similar data was 333 obtained in the second hypoxia trial (β-block trial). In the third trial (combined α+β-blockade), 334 both age groups demonstrated significant increases in norepinephrine during hypoxia, and this 335 was greater in older compared with young adults (P<0.05). Conversely, older adults failed to vasodilate at any level of hypoxia during control conditions 373 ( Figure 2A ). Previous studies on this topic in older adults have utilized only a single level of 374 systemic hypoxia, however the majority of data support our findings of an age-associated 375 impairment in hypoxic vasodilation (11, 27, 29) . Although the net vascular response during 376 systemic hypoxia can be influenced by several factors, we next determined the role of the 377 sympathoadrenal system in regulating vascular tone given that this system is engaged during 378 systemic hypoxia and that aging is associated with chronic elevations in sympathetic nervous 379 system activity and alterations in adrenergic receptor responsiveness. Figure 2B ). These findings suggest that despite a lack of vasodilation in the control 
Effects of Local α-adrenergic Receptor Blockade on Hypoxic Vascular Control
417
In young adults, local inhibition of α-adrenergic mediated vasoconstriction augments 418 peripheral vasodilation during systemic hypoxia (9, 52). As such, the elevated sympathetic 419 outflow (14) and norepinephrine release (32) act to restrain or limit the amount of vasodilation.
420
The data from the present investigation support these previous observations. Specifically, we 
Adrenergic Receptor Responsiveness and Blockade Efficacy
443
In the present study, we determined α-and β-adrenergic receptor responsiveness in both 444 young and older adults via graded intra-arterial doses of norepinephrine and isoproterenol, 
Potential Mechanisms
463
The major key finding from the present study is that the age-associated impairment in 464 peripheral hypoxic vasodilation persists after local inhibition of sympathoadrenal control of 465 vascular tone. Although we found some age-related differences in circulating epinephrine in 466 response to hypoxia (see Table 4 ) and β-adrenergic receptor responsiveness ( Figure 3B ), these 467 observations most likely do not explain our findings related to hypoxic vascular control as β- 
477
The lack of a robust increase in hypoxic vasodilation in the older group during local 478 sympathoadrenal blockade suggests that the age-associated impairment is primarily due to local 
Experimental Considerations
501
There are a few experimental considerations worthy of discussion. First, despite waiting 502 20 minutes between hypoxia trials, there was a general trend for an increase in plasma 503 catecholamine concentrations with repeated hypoxia bouts (Table 4) . For example, compared to 504 the control trial, both young and older adults demonstrated a significant increase in arterial 505 epinephrine concentrations at rest and during hypoxia in the third hypoxia trial (α+β blockade).
506
Additionally, norepinephrine was also significantly elevated in both age groups during the third 507 hypoxic bout. However, it is important to note that any significant increase in epinephrine or 508 norepinephrine with repeated hypoxia exposure in either age group does not impact the 509 interpretation of the peripheral vascular response data, as both α+β-adrenergic receptors (Trial 3) 510 were effectively inhibited in the trial where increases were observed. Further, our arterial 511 catecholamine concentrations are similar to previously reported date in young and older adults at 512 rest and during hypoxia (11, 52).
23
Second, older adults failed to increase heart rate to the same extent as young adults and 514 this was significant across all hypoxia bouts. This is consistent with previous studies on this 515 topic (33) and most likely reflects age-related reductions in cardiac β-adrenergic responsiveness 516 (30, 43). Despite older adults having a significantly smaller increase in heart rate to hypoxia, it 517 is unlikely that this is contributing to the overall age-associated impairment in hypoxic 518 vasodilation, as there is ample heart rate reserve to elevate cardiac output in both age groups at 519 all levels of systemic hypoxia.
520
Finally, although we were not statistically powered to do so, we did examine whether 521 there was any trend for sex differences in the degree of vasodilation to hypoxia within the young 522 and older adult groups (10). In the present study, we did not observe any sex differences in the 523 vasodilatory response to hypoxia nor the impact of the adrenergic blockers on the response, 524 however, given our small sample size, it is unlikely we would be able to detect a significant sex 525 difference.
527
Potential Significance
528
In the present study we determined the effects of healthy aging on the peripheral 529 vasomotor responses to graded systemic hypoxia within the forearm vasculature. The forearm 530 was chosen not only to isolate the local effects of our pharmacological agents, but also due to the 
Conclusions
541
Human aging is associated with a significant impairment in the peripheral vasodilatory 542 response to graded systemic hypoxia. This impairment is independent of age-associated 543 alterations in sympathoadrenal control of vascular tone, and thus it is likely that reductions in the 544 stimulus for local vasodilation (e.g. red blood cell derived ATP) and/or alterations in the local 545 production or bioavailability of endothelium-derived substances (e.g. NO, ET-1), underlie the 546 lack of hypoxic vasodilation in older healthy adults. Peripheral hypoxic vasodilation is also 547 impaired in patient populations that increase in prevalence with advancing age (e.g. heart failure, 548 obstructive sleep apnea), and as such, identifying mechanisms to improve hypoxic vascular 549 control could prove clinically beneficial for older healthy and diseased humans. 
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